首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases
【24h】

Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases

机译:下一代测序及其在系统性自身炎性疾病分子诊断中的初步应用

获取原文
获取原文并翻译 | 示例
       

摘要

Objectives Systemic auto-inflammatory disorders (SAIDs) are a heterogeneous group of monogenic diseases sharing a primary dysfunction of the innate immune system. More than 50% of patients with SAID does not show any mutation at gene(s) tested because of lack of precise clinical classification criteria and/or incomplete gene screening. To improve the molecular diagnosis and genotype interpretation of SAIDs, we undertook the development of a next-generation sequencing (NGS)-based protocol designed to simultaneous screening of 10 genes.
机译:目的全身性自身炎性疾病(SAID)是一组异源性单基因疾病,共有先天性免疫系统功能障碍。由于缺乏精确的临床分类标准和/或不完整的基因筛选,超过50%的SAID患者没有在所测试的基因上显示任何突变。为了改善SAID的分子诊断和基因型解释,我们进行了基于下一代测序(NGS)的协议的开发,该协议旨在同时筛选10个基因。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号